Target intelligence / Profile preview

Archaeal surface layer protein (SLP)

Target
SLP
Molecular classification
Structural protein, Glycoprotein
01

Overview

The Archaeal surface layer (S-layer) is a paracrystalline monomolecular assembly of protein or glycoprotein subunits that constitutes the outermost component of the cell envelope in nearly all Archaea (Sleytr et al., 2014). It serves as a primary structural element, providing mechanical stability, maintaining cell shape, and acting as a selective molecular sieve for nutrient and waste exchange (Albers & Meyer, 2011). Unlike bacterial cell walls that often contain peptidoglycan, many Archaea rely solely on the S-layer for protection against extreme environmental conditions such as high temperature, extreme pH, or high salinity (Rodrigues-Oliveira et al., 2017). The S-layer also facilitates cell-cell interactions and provides a scaffold for the attachment of other surface structures like flagella or pili (Albers & Meyer, 2011). While Archaea are prominent members of the human microbiome, particularly in the gut and oral cavity, they are not currently recognized as primary human pathogens (Gill & Enfield, 2017). Because of this lack of pathogenicity, Archaeal S-layer proteins are not currently utilized as targets for conventional antimicrobial or therapeutic drugs. However, their unique ability to self-assemble into highly ordered lattices makes them valuable in nanobiotechnology for developing drug delivery systems and biosensors (Sleytr et al., 2014). They are also being explored as adjuvant platforms in vaccine development due to their inherent immunogenicity and stability (Sleytr et al., 2014).

Other names
S-layer proteinArchaebacterial cell wall S-layerSurface layer proteinCrystalline cell surface layerArchaeal S-layer
02

Mechanism of action

Not applicable

03

Biological functions

Cell shape maintenanceEnvironmental protectionMolecular sievingCell adhesionIon trappingMechanical stability
04

Disease associations

None established
05

Safety considerations

Lack of known archaeal pathogenicity in humans limits therapeutic relevanceHigh structural and sequence diversity among different archaeal species

Beyond the preview

Go deeper on Archaeal surface layer protein (SLP).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Archaeal surface layer protein (SLP).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call